Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.320
-0.160 (-3.57%)
At close: Aug 24, 2026, 4:00 PM EDT
4.400
+0.080 (1.85%)
After-hours: Aug 24, 2026, 7:30 PM EDT

Camp4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
271318105--
Market Cap Growth
773.14%202.65%---
Enterprise Value
187249274--
Last Close Price
4.486.135.22--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
64.4590.92161.17--
PB Ratio
-6.671.66--
P/TBV Ratio
-6.671.66--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
44.5271.22420.77--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
-3.420.040.140.320.15
Net Debt / Equity Ratio
121.25-2.25-0.88-0.68-0.84
Net Debt / EBITDA Ratio
1.662.131.080.521.60
Net Debt / FCF Ratio
2.933.601.200.581.66
Asset Turnover
0.060.040.010.00-
Quick Ratio
4.537.076.684.9710.56
Current Ratio
4.707.356.925.1310.62
Return on Equity (ROE)
-545.85%-145.07%-101.99%-80.13%-
Return on Assets (ROA)
-45.25%-33.18%-49.80%-41.17%-
Return on Capital Employed (ROCE)
-70.50%-50.90%-77.30%-110.10%-47.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-39.47%-25.28%-49.29%--
FCF Yield
-10.57%-9.38%-43.78%--
Buyback Yield / Dilution
-239.08%-547.76%-1087.44%-26.47%-
SEC Filings: 10-K · 10-Q